MOREPENLAB — Morepen Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹67.69bn
- IN₹69.24bn
- IN₹18.06bn
Launches Empamore For Diabetes, Heart Failure, And Kidney Disease
Brief: Morepen Laboratories Dec-Qtr Net Profit 226.8 Million Rupees
Brief: Morepen Laboratories Approves Hiving Off Medical Devices Business
Brief: Morepen Laboratories Approves Hiving Off Medical Devices Business
Brief: Morepen Laboratories To Incorporate New Unit
Brief: Morepen Laboratories Says Dr. Morepen Targets Revenue Of 300 Mln Rupees In First Year From Lightlife
India's Morepen Laboratories gains on unit's new launch
Brief: Morepen Laboratories Says Sept-Quarter Consol Net Profit At 348.5 Million Rupees
India's Morepen Labs soars to around 13-year high
Brief: Morepen Laboratories June-Quarter Consol Net Profit At 361.7 Million Rupees
Brief: Morepen Laboratories Raises 2 Bln Rupees Via QIP
Brief: Morepen Laboratories Authorised The Opening Of QIP Issue On Aug 1
Brief: Morepen Laboratories March-Quarter Consol Net Profit Rises
Brief: Morepen Laboratories Approved Raising Of Funds Worth Upto 3.5 Bln Rupees
Brief: Morepen Laboratories To Consider Fund Raising
Approved Transfer Of Formulation Distribution & Marketing Business To Morepen Rx
India's Morepen Laboratories surges as profit triples in June quarter
Brief: Morepen Laboratories Says India Supreme Court Orders Stay On Contempt Proceedings Against Co, Directors Pending Before NCLT
India's Morepen Laboratories loses 3% on fall in Q4 earnings